The Translational-Predictive-Adaptive methodology: a Systems-Biology framework for Redox-Driven Host optimization and Terrain priming in CAR T-Cell therapy

IMPORTANT LEGAL NOTICE (2) Barrier Stabilisation — real-time modulation of endothelial tight junction proteins (Zonula Occludens-1, Occludin) and Nrf2 pathway upregulation to prevent BBB degradation and consequent Immune Effector CellAssociated Neurotoxicity Syndrome (ICANS); and (3) Metabolic Persistence Engineering — facilitation of a metabolic switch from anaerobic glycolysis to Fatty Acid Oxidation (FAO) to promote the generation of long-lived memory T-cell subsets (Tscm and Tcm). Patient stratification is governed by an Adaptive Phenotyping Matrix that classifies individuals into three metabolic risk clusters — Hyper-Reactive, Neuro-Vulnerable, and Metabolic-Stasis — determining the duration and dosage of hydrogenomic loading accordingly. Key findings and theoretical contributions The framework proposes that the predominant cause of CAR-T failure in MM is not cellular engineering inadequacy but terrain hostility — a concept operationalised through the translational decoding of biological systems terminology into the molecular language of oncology, bioenergetics, and redox physiology. The methodology constitutes, to the best of the author's knowledge, the first formal integration of systems-biology adaptive phenotyping with Hydrogenomics in a predictive-adaptive clinical model for haematological malignancies. Clinical and Economic Implications Successful implementation of the TPA Method is projected to reduce ICU admissions attributable to CRS and ICANS, preserve the efficacy of the CAR-T biological asset, and contribute to a model of stabilised disease chronicity — redefining oncological remission as durable immunosurveillance rather than episodic cytoreduction.